2
Jan
2025
Investing in Biotech: David Schenkein on The Long Run
David Schenkein is today’s guest on The Long Run. David is a general partner with GV. It’s the corporate venture firm formerly known as Google Ventures. It’s backed by a single limited partner, Alphabet, and has $10 billion in assets under management in 400 active portfolio companies working in tech and life sciences. In this conversation, we talk about turning... Read More